Panitumumab : AMG 954 : Vectibix

(Click on the Study ID to go to the Study Page and view the Lay Summary when it is available)
Study IDStudy Title

A Phase 3, Multicenter, Randomized, Open-label Trial to Evaluate the Survival Benefit of Panitumumab and Best Supportive Care, Compared to Best Supportive Care Alone, in Subjects With Chemorefractory Wild-type KRAS Metastatic Colorectal Cancer